Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Effects of Melatonin in Type 2 Diabetes
NCT03859934Phase 1Completed
- Sponsor
- Aarhus University
- Start
- Sep 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Melatonin with Placebo (2 arms). Primary endpoints: Change of insulin sensitivity at 3 months, Change of insulin secretion at 3 months and 2 more. Started Sep 2019; status: completed.
02
Drugs
melatonin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03859934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03859934.